предыдущий|следующий

Discussion on traditional Chinese medicine connotation and pathogenesis of gastroesophageal reflux disease-related chest pain based on the theory of "relevance of stomach and heart"

  • role： First author第一作者
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

  • Introduction：许高凡，女，在读硕士生
XU Gaofan1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

LI Yading1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

HE Cong1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

LIU Xiaowen1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

WU Yue1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

LIU Yuyang1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

MENG Yangyang1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

WANG Yi1,  
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

ZHU Shengliang1,  
  • role： Corresponding author通信作者
  • Affiliation：

    Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China

  • Email：bingduozhou@163.com
  • Introduction：A/Prof.ZHOU Bingduo, Ph. D., Chief Physician, Master’s Supervisor. Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Hongkou District, Shanghai 200437. E-mail: bingduozhou@163.com
ZHOU Bingduo1*

реферат

Among all atypical gastroesophageal reflux disease (GERD)-related symptoms, chest pain is the most important one. The theory of "relevance of stomach and heart" can guide the discussion on traditional Chinese medicine connotation and pathogenesis of GERD-related chest pain. We named GERD-related chest pain as "alimentary epigastralgia". Its pathological mechanism is failure of gastric qi to descend, combined with obstruction of thoracic collaterals. The disease location is the esophagus and stomach, resulting in pain in esophagus and heart. The syndrome can be divided into four types: liver qi affecting the stomach, phlegm dampness obstructing, stagnant blood obstructing the collaterals, and inactivity of thoracic yang. The commonest clinical subtype is inactivity of thoracic yang, which is caused by disordered qi activity, ascending of turbid yin, and obstruction due to phlegm and qi. In clinical practice, the main therapeutic principle is to diffuse blockage and free yang and descend qi to resolve phlegm, and the basic formula is Zhishi Xiebai Guizhi Decoction, with variations according to the symptoms. Modern research suggests that abnormal acid reflux, the esophagus-heart reflex pathway, the brain-gut axis, and other important pathogeneses all reflect the theory of "relevance of stomach and heart" .

ключеви́че слова́

relevance of stomach and heart;gastroesophageal reflux disease-related chest pain;traditional Chinese medicine connotation;pathogenesis

References

  1. [1].
    KATZ PO, DUNBAR KB, SCHNOLL-SUSSMAN FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease[J] .Am J Gastroenterol, 2022, 117：27－56.
  2. [2].
    VAKIL N, VAN ZANTEN SV, KAHRILAS P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8)：1125－1140.
  3. [3].
    汪忠镐，吴继敏，胡志伟，等．中国胃食管反流病多学科诊疗共识[J].中华胃食管反流病电子杂志，2020，7(1)：1－28.
  4. [4].
    FASS R, ACHEM SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis[J].J Neurogastroenterol Motil, 2011，17(2)：110－123.
  5. [5].
    FORD AC, SUARES NC, TALLEY NJ. Meta-analysis: Epidemiology of non-cardiac chest pain in the community[J]. Aliment Pharmacol Ther, 2011, 34(2)：172－180.
  6. [6].
    CHEN MH, XIONG LS, CHEN HX, et al. Prevalence, risk factors and impact of gastroesophageal reflux disease symptoms: A population-based study in South China[J/OL]. Scand J Gastroenterol, 2005, 40(7)：759[2022－12－06]. .
  7. [7].
    宋洪涛，李志刚．“胃与心相通”理论探讨[J].吉林中医药，2013，33(10)：975－977.
  8. [8].
    李程，范登脉，李先涛．《黄帝内经》“心与脾胃相关”理论发微[J].广州中医药大学学报，2018，35(5)：920－923.
  9. [9].
    邢玉瑞，何伟，胡勇．中医心与阳明胃病症关系的历史演变[J].中华中医药杂志，2020，35(4)：2093－2095.
  10. [10].
    展立芬，邢博文，覃思敏，等．基于藏象学说的心、肝、胃同治在功能性消化不良中的运用探讨[J].时珍国医国药，2021，32(11)：2726－2729.
  11. [11].
    HERREGODS TVK, BREDENOORD AJ, OORS JM, et al. Determinants of the Association between Non-Cardiac Chest Pain and Reflux[J/OL]. Am J Gastroenterol, 2017：288 [2022－12－06]. .
  12. [12].
    BEEDASSY A, KATZ PO, GRUBER A, et al. Prior sensitization of esophageal mucosa by acid reflux predisposes to reflux-induced chest pain[J]. J Clin Gastroenterol, 2000, 31(2)：121－124.
  13. [13].
    DE MEESTER TR, O′SULLIVAN GC, BERMUDEZ G, et al. Esophageal function in patients with angina-type chest pain and normal coronary angiograms [J/OL]. Ann Surg, 1982, 196(4)：488 [2022－12－06]. .
  14. [14].
    SMITH JL, OPEKUN AR, LARKAI E, et al. Sensitivity of the esophageal mucosa to ph in gastroesophageal reflux disease[J/OL]. Gastroenterology, 1989 ：2914634 [2022－12－06]. .
  15. [15].
    许军英，陈婕，谢小平，等．胃十二指肠混合反流在食管黏膜损伤中的作用[J].中华消化杂志，2003，23(4)：48－49.
  16. [16].
    RIBOLSI M, BALESTRIERI P, BIASUTTO D, et al. Role of mixed reflux and hypomotility with delayed reflux clearance in patients with non-cardiac chest pain[J]. J Neurogastroenterol Motil, 2016, 22(4)：606－612.
  17. [17].
    FARRĔ R, BLONDEAU K, CLEMENT D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique[J]. Gut, 2011, 60(7)：885－892.
  18. [18].
    MIN YW, RHEE PL. Esophageal hypersensitivity in noncardiac chest pain[J]. Ann N Y Acad Sci, 2016, 1380：27－32.
  19. [19].
    CHENG S, HAYAKAWA T, KUCHIIWA S, et al. Evidence for the collateral innervation of the esophagus and the heart from neurons in the compact formation of the nucleus ambiguus of the rat[J]. Brain Research, 1999, 832(1－2)：171－174.
  20. [20].
    ROSZTǑCZY A, VASS A, IZBĔKI F, et al. The evaluation of gastro-oesophageal reflux and oesophagocardiac reflex in patients with angina-like chest pain following cardiologic investigations[J]. Int J Cardiol, 2007, 118(1)：62－68.
  21. [21].
    GARCIA-PULIDO J, PATEL PH, HUNTER WC，et al. Esophageal contribution to chest pain in patients with coronary artery disease[J] .Chest, 1990. 98(4): 806－810.
  22. [22].
    TERAGAWA H, OSHITA C, UEDA T. History of gastroesophageal reflux disease in patients with suspected coronary artery disease[J]. Heart and Vessels, 2019，34(10): 1631－1638.
  23. [23].
    DOBRZYCKI S, BANIUKIEWICZ A, KORECKI J, et al. Does gastro-esophageal reflux provoke the myocardial ischemia in patients with CAD? [J]. Int J Cardiol, 2005, 104(1)：67－72.
  24. [24].
    祝捷，李宇航，王庆国，等．半夏泻心汤对功能性消化不良大鼠胃排空及血浆胃动素的影响[J].中华中医药杂志，2005，20(6)：335－337.
  25. [25].
    周肸，钱海华，张丹，等. 基于肠道菌群与脑肠轴的相互作用机理探讨中医脑肠学说[J].中华中医药学刊，2020, 38(3)：119－122.
  26. [26].
    周彦妮，陈敏，杨焱麟，等. 基于脑肠轴的肠道菌群调控腹泻型肠易激综合征的研究进展[J].中华中医药杂志，2022，37 (3)：1582－1586.
  27. [27].
    熊林林，舒青龙，唐芳瑞，等. 基于“脑肠轴”的中医药微生态研究进展[J]. 时珍国医国药，2021, 32(6)：1438－1443.
  28. [28].
    CHEUNG TK, HOU XH, LAM KF, et al. Quality of life and psychological impact in patients with noncardiac chest pain[J]. J Clin Gastroenterol, 2009, 43(1)：13－18.
  29. [29].
    MEERVELD BGV, JOHNSON AC. Mechanisms of Stress-induced Visceral Pain[J]. J Neurogastroenterol Motil, 2018. 24(1)：7－18.
  30. [30].
    何聪，许高凡，周秉舵，等．胃食管反流病相关性胸痛之“食心痛”命名及辨治探微[J].中医杂志，2022，63(5)：425－429.
  31. [31].
    朱生樑．胃食管反流病基础与中西医临床[M].上海：上海科学技术出版社，2015：90.
  32. [32].
    周秉舵，王晓素．通化宣平，圆执活变：朱生樑脾胃病临证经验集[M].北京：人民卫生出版社，2021：234.
  33. [33].
    黄梅芳，刘启鸿，蔡华珠．心胃相关之刍议[J].陕西中医药大学报，2019，42(4)：60－62.
  34. [34].
    孔令彪，江琪，李颖，等．心胃学说理论探讨[J].北京中医药，2014，33(12)：928－929.
  35. [35].
    冀召帅，吴以岭，贾振华，等．薤白对气滞型血管损伤COX－2和iNOS含量及相互作用的影响[J].北京中医药大学学报，2008，31(12)：835－838.
  36. [36].
    区文超，钟赟，刘本荣，等．薤白皂苷化合物对CD40L表达及血小板中性粒细胞黏附的影响[J].广东医学，2011，32(7)：833－835.
  37. [37].
    和焕香，郭庆梅．瓜蒌化学成分和药理作用研究进展及质量标志物预测分析[J].中草药，2019，50(19)：4808－4820.
  38. [38].
    程弘夏，李佩，许腊英．厚朴及姜厚朴乙酸乙酯提取部位对小鼠胃肠运动功能的影响[J].中国实验方剂学杂志，2014，20(24)：143－146.
  39. [39].
    黄爱华，迟玉广，曾元儿，等．枳实黄酮对功能性消化不良大鼠胃肠动力的影响[J].中药新药与临床药理，2012，23(6)：612－615.
  40. [40].
    HAMDAN DI, MAHMOUD MF, WINK M, et al. Effect of hesperidin and neohesperidin from bittersweet orange (Citrus aurantium var. bigaradia) peel on indomethacin-induced peptic ulcers in rats[J]. Environ Toxicol Pharmacol, 2014, 37(3)：907－915.
  41. [41].
    霍海如，谭余庆，周爱香，等．桂枝汤有效部位B对胃肠运动双向调节作用的实验研究Ⅵ：对cAMP、蛋白激酶A和C活性的影响[J].中国实验方剂学杂志，2005，11(4)：51－54.
  42. [42].
    王朝阳，睢明河，刘清国，等．心病治从阳明的针灸思路探讨[J].北京中医药大学学报(中医临床版)，2011，18(5)：40－42.
  43. [43].
    齐卓操，王键，郭锦晨，等．基于通阳理论的新安王氏内科脾胃病用药规律数据挖掘研究[J].北京中医药大学学报，2019，42(8)：691－696.
  44. [44].
    严坤立．周福生教授心胃相关理论辨治慢性胃炎的临床运用探讨[D].广东：广州中医药大学，2014.
  45. [45].
    徐静，孔令彪．“心胃同治”理论治疗胸痹临床体会[J].北京中医药，2016，35(11)：1051－1052.
  46. [46].
    贾云芳，侯仙明，王文智，等．以归经理论为切入点探讨冠心病之心肝胃同治思想[J].中国中医基础医学杂志，2013，19(3)：247－248.

Читать полностью

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website